<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00343122</url>
  </required_header>
  <id_info>
    <org_study_id>EK 4462005</org_study_id>
    <nct_id>NCT00343122</nct_id>
  </id_info>
  <brief_title>Echocardiographic Assessment of Intrapulmonary Vasodilatation: Agitated Saline Versus Polygeline</brief_title>
  <official_title>Evaluation of Two Methods for the Echocardiographic Assessment of Intrapulmonary Vasodilatation in Patients With Liver Cirrhosis: Agitated Saline Versus Polygelatine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate agitated saline versus polygeline for detection of
      intrapulmonary vasodilatation in patients with cirrhosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intrapulmonary vasodilatation is a frequent finding in patients with cirrhosis. Its diagnosis
      is established via contrast enhanced echocardiography. One used method is the contrast agent
      agitated saline and another frequently used method is the contrast agent polygeline. The
      purpose of this study is to compare these two echocardiographic contrast agents with respect
      to their ability to detect intrapulmonary vasodilatation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2006</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Liver</condition>
  <condition>Cirrhosis</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>echocardiography for intrapulmonary vasodilatation</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years

          -  presence of liver cirrhosis

          -  evaluation for liver transplantation or transjugular intrahepatic portosystemic shunt

        Exclusion Criteria:

          -  inadequate echocardiographic image quality

          -  allergies to echocardiographic contrast agents

          -  pulmonary valve stenosis

          -  pulmonary embolism

          -  relevant tricuspid regurgitation

          -  cardiomyopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Schenk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intensive Care Unit 13h1, Dep. of Internal Medicine IV, Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valentin Fuhrmann, MD</last_name>
    <phone>0043-1-40400</phone>
    <phone_ext>4766</phone_ext>
    <email>valentin.fuhrmann@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Peter Schenk, MD</last_name>
    <phone>0043-1-40400</phone>
    <phone_ext>4766</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Intensive Care Unit 13H1, Dep. of Internal Medicine IV, Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valentin Fuhrmann, MD</last_name>
      <phone>0043-1-40400</phone>
      <phone_ext>4766</phone_ext>
      <email>valentin.fuhrmann@meduniwien.ac.at</email>
    </contact>
    <investigator>
      <last_name>Peter Schenk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valentin Fuhrmann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB; ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J. 2004 Nov;24(5):861-80. Review.</citation>
    <PMID>15516683</PMID>
  </reference>
  <verification_date>September 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2006</study_first_submitted>
  <study_first_submitted_qc>June 20, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2006</study_first_posted>
  <last_update_submitted>September 14, 2007</last_update_submitted>
  <last_update_submitted_qc>September 14, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2007</last_update_posted>
  <keyword>liver</keyword>
  <keyword>cirrhosis</keyword>
  <keyword>hepatopulmonary syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

